Abstract: The present invention relates to a device (1, 1?) and a method for simultaneously measuring a plurality of blood parameters by means of artificial intelligence. The invention provides for: exciting blood with electromagnetic radiation at a plurality of determined wavelengths, receiving analog information relating to the plurality of electromagnetic and/or light responses of the blood comprising electromagnetic radiation retroreflected or diffused by the blood, converting the analog electromagnetic and/or light response information into digital electromagnetic and/or light response data, processing the digital electromagnetic and/or light response data and the actual temperature value of the blood by means of one or more neural networks (NN) and determining, as a result of the processing operation, the value of each parameter.

Abstract: The present invention relates to a device (1, 1?) and a method for simultaneously measuring a plurality of blood parameters by means of artificial intelligence. The invention provides for: exciting blood with electromagnetic radiation at a plurality of determined wavelengths, receiving analog information relating to the plurality of electromagnetic and/or light responses of the blood comprising electromagnetic radiation retroreflected or diffused by the blood, converting the analog electromagnetic and/or light response information into digital electromagnetic and/or light response data, processing the digital electromagnetic and/or light response data and the actual temperature value of the blood by means of one or more neural networks (NN) and determining, as a result of the processing operation, the value of each parameter.

Abstract: The present invention refers to a device (1) and a method of measuring a parameter of blood, preferably correlated to the presence or concentration of oxygen in blood. The invention provides to: excite a photosensitive element (18?) in contact with blood by excitation pulses, detect light responses of the photosensitive element corresponding to the excitation pulses, and analyze the plurality of luminescence decay curves at least two time windows (t1-tN). Moreover, the invention provides to: detect one or more light answer analog information regarding the luminescence curve decay at each time window, convert the analog information into digital data, process the digital data and the actual temperature value of blood by taking into account a plurality of data of previous measures of the parameter of blood performed during a previous training, and determine, as a result of the processing step, at least one value of said parameter of blood.

Abstract: The present invention refers to a device (1) and a method of measuring a parameter of blood, preferably correlated to the presence or concentration of oxygen in blood. The invention provides to: excite a photosensitive element (18?) in contact with blood by excitation pulses, detect light responses of the photosensitive element corresponding to the excitation pulses, and analyze the plurality of luminescence decay curves at least two time windows (t1-tN). Moreover, the invention provides to: detect one or more light answer analog information regarding the luminescence curve decay at each time window, convert the analog information into digital data, process the digital data and the actual temperature value of blood by taking into account a plurality of data of previous measures of the parameter of blood performed during a previous training, and determine, as a result of the processing step, at least one value of said parameter of blood.

Abstract: An apparatus for measuring the blood parameters in an extracorporeal circuit comprises: a seat (23) suitable for containing a duct (14) for the blood flow of said extracorporeal circuit; emitting means (16) and detecting means (18) of electromagnetic radiation that face the seat (23); a control unit (38) to which said emitting means (16) and detecting means (18) are connected. The apparatus according to the invention is characterised in that the emitting means (16) are suitable for producing electromagnetic radiation at different wavelengths, and the detecting means (18) are suitable for detecting the electromagnetic radiation diffused in the blood at said wavelengths. Moreover, the apparatus is characterised in that the control unit (38) is suitable for calculating values of blood parameters through a correlation between reference values and ratios obtained from values of the light intensity of the radiation detected at at least two different wavelengths.

Abstract: A method for measuring the mean velocity (VH) of an extracorporeal blood fluid or infusion fluid, by means of retroinjection interferometry, comprises the step of emitting a first laser light beam (41), from the laser cavity (40) of a semiconductor laser source (60), reflection of a second laser beam (45) by the fluid (50) and consequent generation of interference with the first laser beam (41) inside the laser cavity (40), detection of the interference signal by a monitoring photodiode (46), and processing, by means of an electronic processing and control circuit (100), of the interference signal detected. The invention also comprises an apparatus (62) for implementing the method described and an extracorporeal circuit (58) comprising said apparatus. The invention also comprises a method for replacing a laser source in said apparatus.

Abstract: Complexes of saponins from Centella asiatica, terminalia sp. and Terminalia sericea and relevant aglycons with phospholipids are described. The saponins may be asiaticoside, madecassicoside and sericoside. The molar ratio of phospholipids to saponins is from 0.5 to 2. The phospholipids are selected from the group consisting of soy lecithins, phospholipids from bovine or swine brain or cutis, phosphatidylcholine, phosphatidylserine, phosphatidylethanolamine in which the acyl groups can be the same or different and are mostly derived from palmitic, stearic, oleic, linoleic, linolenic acids. Pharmaceutical compositions and the method of treatment are also described.

Abstract: Complexes of glycyrrhetinic acid with phospholipids are described in which the molar ratio of phospholipids to glycyrrhetinic acid is from 0.5 to 2. The phospholipids are selected from the group consisting of soy lecithins, phospholipids from bovine or swine brain or cutis, phosphatidylcholine, phosphatidylserine, phosphatidylethanolamine in which the acyl groups can be the same or different and are mostly derived from palmitic, stearic, oleic, linoleic, linolenic acids. The phospholipid may be soy phosphatidylcholine or distearoylphosphatidylcholine. Pharmaceutical compositions and a method for producing anti-inflammatory, antiulcer and healing effects in an animal are also described.

Abstract: Complexes formed between aescin, cholesterol or .beta.-sitosterol and phospholipids are described. The molar ratio of phospholipids to aescin/.beta.-sitosterol or cholesterol is from 0.5 to 2. The phospholipids are selected from the group of soy or egg lecithins, phospholipids from bovine or swine brain or cutis, phosphatidylcholine, phospatidylserine, phosphatidylethanolamine in which the acyl groups may be the same or different and are mostly derived from palmitic, stearic, oleic, linoleic, linolenic acids, for instance, pharmaceutical compositions and a method for producing an anti-inflammatory effect in an animal are also described.